版权说明 操作指南
首页 > 成果 > 详情

Comparative Efficacy of Seven Chinese Patent Medicines for Early Diabetic Kidney Disease: A Bayesian Network Meta-Analysis

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Zhao, Jie;Ai, Jun;Mo, Chao;Shi, Wei;Meng, LiFeng
作者机构:
[Zhao, Jie] Hunan Univ Chinese Med, Grad Sch, Changsha 410208, Hunan, Peoples R China.
[Ai, Jun] Guangxi Univ Chinese Med, Basic Med Sch, Nanning 530200, Guangxi, Peoples R China.
[Shi, Wei; Meng, LiFeng; Mo, Chao] Guangxi Univ Chinese Med, Affiliated Hosp 1, Dept Nephrol, 327 Xian Hu Rd, Nanning 530023, Guangxi, Peoples R China.
[Mo, Chao] Guangxi Univ Chinese Med, Grad Sch, Nanning 530200, Guangxi, Peoples R China.
[Meng, LiFeng] Southwest Med Univ, Tradit Chinese & Western Med Lab Controlling Orga, Luzhou 646000, Sichuan, Peoples R China.
语种:
英文
关键词:
24 -h UTP;24-h urinary total protein;ACEI;angiotensin-converting enzyme inhibitor;ARB;angiotensin receptor blocker;AEs;adverse events;BLC;Bailing capsule;BUN;blood urea nitrogen;CXC;Compound Xueshuantong capsule;CPMs;Chinese patent medicines;CRP;c-reactive protein;CrI;credible intervals;DM;diabetes mellitus;DKD;diabetic kidney disease;HKC;Huangkui capsule;JSB;Jinshuibao;MD;mean difference;NMA;network meta-analysis;OR;odds ratio;RCT;randomized controlled trials;SYKFT;Shenyan Kangfu tablet;SCr;serum creatinine;SUCRA;surface under the cumulative ranking curve area;TG;Tripterygium glycosides;TRIG;triglyceride;TC;total cholesterol;TCM;Traditional Chinese medicine;UCG;Uremic Clearance granule;UAER;urinary albumin excretion rate;diabetic kidney disease;Chinese Patent Medicine;network meta-analysis;randomized controlled trials;angiotensin-converting enzyme inhibitors;angiotensin receptor blockers
期刊:
Complementary Therapies in Medicine
ISSN:
0965-2299
年:
2022
卷:
67
页码:
102831
机构署名:
本校为第一机构
院系归属:
研究生院
摘要:
BACKGROUND: Bailing Capsule (BLC), Jinshuibao (JSB), Huangkui Capsule (HKC), Uremic Clearance Granule (UCG), Tripterygium glycosides (TG), Compound Xueshuantong Capsule (CXC), and Shenyan Kangfu Tablet (SYKFT) as classic Chinese patent medicines (CPMs), have been widely used and shown beneficial effects on the treatment of early diabetic kidney disease (DKD). However, the comparative efficacy of seven CPMs in the treatment of early DKD remains unknown. OBJECTIVE: To evaluate and compare the efficacy of seven CPMs (BLC, JSB, HKC, UCG, TG, CXC, SYKFT) combined with angiotensin-converting enzyme ...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com